Reviewed by Nazia Q Bandukwala, DO on May 14, 2019
SOURCES:
U.S. National Library of Medicine: “Darifenacin,” “Mirabegron,” “Tolterodine,” “Oxybutynin Transdermal Patch,” “Oxybutynin Topical,” “Solifenacin,” “Trospium,”
National Institutes of Health: “Fesoterodine.”
Medscape: “Overactive Bladder Treatment & Management,” “Overactive Bladder Medication.”
Mayo Clinic: “Overactive Bladder,” “Oxybutynin (Oral Route).”
Urology Care Foundation: “What is Overactive Bladder?”
Wake Forest Baptist Health: “A Guide to Managing Overactive Bladder.”
American Family Physician: “AUA Releases Guideline on Diagnosis and Treatment of Overactive Bladder.”
Cleveland Clinic: “Are Your Medications Causing or Increasing Incontinence?”
The Cystitis & Overactive Bladder Foundation: “OAB Diet.”
Bladder & Bowel Community: “10 Overactive Bladder Treatment Options To Try.”
Columbus Regional Healthcare System: “Bladder Matters: A Guide to Managing Overactive Bladder.”
Reviews in Urology: “Smoking: Its Impact on Urologic Health.”
National Institute on Aging: “Urinary Incontinence in Older Adults.”
American Urological Association: “Diagnosis and Treatment of Non-Neurogenic Overactive Bladder (OAB) in Adults (2019).”
University of Colorado: “Try PTNS for Overactive Bladder.”
© 2019 WebMD, LLC. All rights reserved.